Study guide

4.1 General & Systemic Pathology

Integrated National Board Dental Examination INBDE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: INBDE Exam Structure & Test Specifications

1.1 INBDE Format, Administration, Scoring & Retesting 1.2 The Domain of Dentistry: Test Specifications, Item Formats, Patient Boxes & Dental Charts

2 Chapter 2: Foundation Knowledge — Anatomic Sciences & Development

2.1 Gross & Head/Neck Anatomy and Histology 2.2 Oral Embryology, Tooth Development & Eruption 2.3 Genetic, Congenital & Developmental Conditions

3 Chapter 3: Foundation Knowledge — Biochemistry, Physiology & Physical Sciences

3.1 Biochemistry and Systemic Physiology 3.2 Physics & Chemistry of Oral Biology: pH, Diffusion & Demineralization

4 Chapter 4: Foundation Knowledge — Pathology, Microbiology & Immunology

4.1 General & Systemic Pathology 4.2 Microbiology, Immunology, and Infection Pathogenesis

5 Chapter 5: Foundation Knowledge — Pharmacology

5.1 Dental Pharmacology, Local Anesthetics, and Analgesics 5.2 Systemic Medications and Drug Interactions in Dentistry

6 Chapter 6: Foundation Knowledge — Dental Anatomy, Occlusion & Materials

6.1 Tooth Morphology, Anatomy, and Occlusion Biomechanics 6.2 Dental Materials Science, Biomaterials, and Impression Systems

7 Chapter 7: Patient Evaluation & Data Gathering

7.1 Chief Complaint, History Taking & Information from Diverse Sources 7.2 Comprehensive Patient History, Examination, and Medical Risk Assessment 7.3 Vital Signs, ASA Physical Status & Medical Risk Stratification 7.4 Normal Findings vs Significant Deviations Requiring Management

8 Chapter 8: Diagnostic Imaging

8.1 Dental Radiology Physics, Safety, and Imaging Interpretation 8.2 Intraoral Radiographic Technique, Errors & Quality Assurance 8.3 Radiographic Interpretation of Caries, Periapical & Bone Lesions 8.4 Panoramic, CBCT & Selection Criteria for Advanced Imaging

9 Chapter 9: Diagnostic Reasoning & Systemic Assessment

9.1 Diagnostic Testing, Laboratory Values, and Medical Complexities 9.2 Predictive Diagnostic Reasoning & Selecting the Right Diagnostic Test 9.3 Oral–Systemic Interrelationships 9.4 Differential Diagnosis of Orofacial Pain

10 Chapter 10: Oral Pathology & Mucosal Disease

10.1 Benign and Malignant Oral Pathology and Biopsy Protocols 10.2 Managing Oral Mucosal and Osseous Diseases

11 Chapter 11: Treatment Planning, Prognosis & Communication

11.1 Interdisciplinary Treatment Planning Sequencing and Prognosis 11.2 Prognosis Determination & Presenting Treatment Alternatives 11.3 Informed Consent, Refusal & Patient Education 11.4 Patient Attributes, Culture, Social Background & Care Across the Lifespan 11.5 Psychological, Social & Behavioral Principles in Patient Communication 11.6 Evaluating the Outcomes of Comprehensive Dental Care

12 Chapter 12: Medical & Dental Emergencies

12.1 Dental and Medical Emergencies in the Dental Office 12.2 Recognizing and Triaging Dental Emergencies

13 Chapter 13: Caries, Operative & Esthetic Dentistry

13.1 Caries Risk Assessment, Prevention, and Operative Dentistry 13.2 Adhesive Dentistry, Composite/Amalgam Restorations, and Esthetics 13.3 Managing the Esthetic Needs of Patients

14 Chapter 14: Endodontics

14.1 Pulpal Biology, Endodontic Diagnosis, and Emergency Treatment 14.2 Endodontic Therapy, Root Canal Instrumentation, Obturation, and Surgery

15 Chapter 15: Periodontics & Implantology

15.1 Periodontal Pathogenesis, Etiology, and Disease Classification 15.2 Non-Surgical Periodontal Therapy and Maintenance Protocols 15.3 Surgical Periodontics, Mucogingival Procedures, and Regenerative Care 15.4 Dental Implants: Planning, Surgical Placement, and Restorative Options

16 Chapter 16: Prosthodontics & Laboratory Communication

16.1 Fixed Prosthodontics: Crown/Bridge Preparation, Design, and Cementation 16.2 Removable Complete Dentures: Impression, Occlusion, and Delivery 16.3 Removable Partial Dentures: Components, Design, and Frameworks 16.4 Communicating Case Design to the Dental Laboratory

17 Chapter 17: Pain Control, Anesthesia & Oral Surgery

17.1 Local Anesthetic Techniques, Complications, and Nitrous Oxide Sedation 17.2 Dentoalveolar Surgery, Tooth Extraction, and Surgical Complications 17.3 Maxillofacial Trauma, Odontogenic Infections, and Complex Surgery

18 Chapter 18: Occlusion, TMD & Orthodontics

18.1 Craniofacial Growth, Development, and Orthodontic Diagnosis/Intervention 18.2 Developmental & Acquired Occlusal Problems 18.3 Temporomandibular Disorders: Diagnosis and Management

19 Chapter 19: Pediatric, Special Care & Vulnerable Patients

19.1 Pediatric Dental Care, Behavior Guidance, and Preventive Services 19.2 Pediatric Restorative Dentistry, Pulpal Therapy, and Dental Trauma 19.3 Special Care Dentistry: Geriatric, Special Needs, and Medically Compromised Patients 19.4 Recognizing, Managing & Reporting Patient Abuse and Neglect 19.5 Recognizing and Managing Substance Use Disorders

20 Chapter 20: Practice Management, Safety Systems & Informatics

20.1 Infection Control Protocols, Sterilization, and OSHA Compliance 20.2 Radiation Safety Guidelines, Dosimetry, and ALARA Principles 20.3 Practice Business Operations, OSHA & Regulatory Compliance 20.4 Catastrophe Preparedness & Practice Continuity Planning 20.5 Managing, Coordinating & Supervising Allied Dental Personnel 20.6 Quality Assurance, Assessment and Improvement 20.7 Dental Informatics, Electronic Records & Emerging Technology 20.8 Scope of Competence, Referral & Professional Self-Assessment

21 Chapter 21: Ethics, Jurisprudence, Evidence & Public Health

21.1 ADA Ethics Code, Jurisprudence, HIPAA, and Professional Conduct 21.2 Evidence-Based Dentistry, Clinical Epidemiology, and Dental Public Health 21.3 Biostatistics, Study Design & Critical Appraisal 21.4 Community Collaboration & Systems of Oral Health Care Delivery 21.5 Emerging Trends and Social/Economic Forces in Oral Health Care 21.6 Prevention, Intervention & Patient Education Strategies

4.1 General & Systemic Pathology

Key Takeaways Explain This Topic AI

Metaplasia is a reversible substitution of one adult cell type for another (e.g., Barrett's esophagus: squamous to columnar; smoker's trachea: columnar to squamous)

Coagulative necrosis preserves underlying cell outlines ('ghost cells') and is typical of ischemic infarcts in all organs EXCEPT the brain (which undergoes liquefactive necrosis)

Prostaglandin E2 (PGE2) induces fever, vasodilation, and pain sensitization; Leukotriene B4 (LTB4) is a potent neutrophil chemoattractant

Heerfordt syndrome (uveoparotid fever) is a manifestation of Sarcoidosis featuring non-caseating granulomas, parotid enlargement, anterior uveitis, and CN VII facial palsy

Carcinoma in situ (CIS) represents full-thickness epithelial dysplasia without breaching the basement membrane; Hypertensive crisis (BP >180/110 mmHg) requires deferring elective dental care

Last updated: August 2026

  • 1.3 General & Systemic Pathology
  • Cellular Adaptations, Cell Injury & Nuclear Morphologies

Cells respond to physiologic demands and stress by adapting. When stress exceeds adaptive capacity, cell injury occurs.

Cellular Adaptation Mechanisms

Hypertrophy : Increase in cell size , resulting in increased organ size (e.g., left ventricular hypertrophy in systemic hypertension).

Hyperplasia : Increase in cell number due to cellular proliferation (e.g., drug-induced gingival hyperplasia secondary to Phenytoin, Nifedipine, or Cyclosporine).

Atrophy : Decrease in cell size and functional capacity due to reduced workload, loss of innervation, diminished blood supply, or inadequate nutrition.

Metaplasia : Reversible replacement of one mature adult cell type by another adult cell type better able to withstand the adverse environment.

Barrett's Esophagus : Esophageal stratified squamous epithelium → intestinal columnar epithelium with goblet cells (due to chronic gastric acid reflux).

Smoker's Respiratory Tract : Ciliated pseudostratified columnar epithelium → stratified squamous epithelium.

Reversible vs. Irreversible Cell Injury

Reversible Injury : Marked by cellular swelling (hydropic change due to Na+/K+-ATPase pump failure), plasma membrane blebbing, ribosome detachment, and fatty change (steatosis).

Irreversible Injury (Cell Death) : Defined by permanent mitochondrial dysfunction (inability to synthesize ATP) and massive loss of membrane integrity. Nuclear changes follow a strict progression:

Pyknosis : Nuclear shrinkage and increased basophilia/hyperchromasia.

Karyorrhexis : Fragmentation of the pyknotic nucleus.

Karyolysis : Dissolution of the nucleus by endonucleases.

Morphologic Patterns of Tissue Necrosis vs. Apoptosis

Necrosis Pattern Histologic Features Typical Etiology & Tissue

Coagulative Denaturation of structural proteins; preservation of basic cellular architecture for days ("ghost cells") Ischemic infarction of all solid organs EXCEPT the brain (heart, kidney, spleen)

Liquefactive Rapid enzymatic digestion of tissue, converting it into a liquid viscous mass (pus) Ischemic stroke in the Central Nervous System (Brain) ; focal bacterial/fungal abscesses

Caseous Friable, yellow-white, "cheese-like" gross appearance; tissue structure completely destroyed Granulomatous infection by Mycobacterium tuberculosis

Fat Action of lipases releasing free fatty acids that combine with calcium to form chalky-white deposits ( saponification ) Acute pancreatitis; traumatic breast injury

Fibrinoid Deposition of antigen-antibody immune complexes and fibrin in arterial walls Autoimmune vasculitis; malignant hypertension

Mechanisms of Apoptosis

Apoptosis is an energy-dependent programmed cell death affecting single cells without eliciting an inflammatory response. INTRINSIC (MITOCHONDRIAL) PATHWAY:

Cell Stress / DNA Damage → Pro-apoptotic proteins (Bax, Bak) → Cytochrome c release from Mitochondria → Activates Caspase-9

EXTRINSIC (DEATH RECEPTOR) PATHWAY:

FasL binding to Fas (CD95) or TNF binding to TNF-R → Recruits FADD → Activates Caspase-8

CONVERGENCE ON EXECUTIONER CASPASES:

  • Caspases-3 and 6 activated → Cleave cytoskeleton & activate Endonucleases → Apoptotic Bodies → Phagocytosis
  • Acute vs. Chronic Inflammation & Chemical Mediators
  • Acute Inflammation Dynamics

Characterized by rapid onset, short duration, exudation of fluid/plasma proteins (edema), and predominantly neutrophil (PMN) emigration.

Vascular Events : Transient vasoconstriction followed by arteriolar vasodilation (increased blood flow / rubor and calor) and increased microvascular permeability (protein-rich exudate / tumor).

Leukocyte Extravasation Sequence : Marginations → Rolling (mediated by Selectins ) → Firm Adhesion (mediated by Integrins ) → Transmigration / Diapedesis (via PECAM-1 / CD31 ) → Chemotaxis (guided by LTB4, C5a, IL-8, bacterial N-formyl peptides).

Key Chemical Mediators

Histamine : Released by mast cell degranulation; causes rapid arteriolar vasodilation and endothelial contraction producing interendothelial gaps.

Arachidonic Acid Metabolites (Eicosanoids) :

COX Pathway (Prostaglandins) : PGE2 induces fever (hypothalamic reset), vasodilation, and sensitizes nerve endings to pain. PGI2 (Prostacyclin) inhibits platelet aggregation. Thromboxane A2 (TXA2) promotes platelet aggregation and vasoconstriction.

Lipoxygenase Pathway (Leukotrienes) : LTB4 is a potent chemoattractant for neutrophils. LTC4, LTD4, LTE4 (slow-reacting substances of anaphylaxis) induce intense bronchospasm and increased vascular permeability.

Granulomatous Inflammation: Tuberculosis & Sarcoidosis

Granulomatous inflammation is a specialized pattern of chronic inflammation characterized by microscopic aggregates of transformed, activated macrophages called epithelioid histiocytes , surrounded by a collar of lymphocytes, plasma cells, and multinucleated giant cells.

Tuberculosis (TB)

Etiology : Infection by Mycobacterium tuberculosis (acid-fast bacillus detected via Ziehl-Neelsen stain).

Histopathology : Caseating granulomas featuring central caseous necrosis surrounded by epithelioid macrophages and Langhans giant cells (nuclei arranged in a horseshoe pattern at the cell periphery).

Oral Lesions : Chronic, painful, non-healing indurated ulcer, most commonly found on the dorsum of the tongue .

Sarcoidosis

Etiology : Systemic non-infectious autoimmune disease of unknown origin.

Histopathology : Non-caseating granulomas (lacking central necrosis) containing Schaumann bodies and asteroid bodies.

Clinical Presentation : Pulmonary hilar lymphadenopathy and lung involvement.

Heerfordt Syndrome (Uveoparotid Fever) : Classic sarcoidosis triad featuring bilateral parotid enlargement , anterior uveitis , facial nerve palsy (CN VII) , and low-grade fever.

  • Neoplasia Principles, Dysplasia & TNM Staging
  • Benign vs. Malignant Neoplasms

Benign : Well-differentiated, slow growing, expansive, encapsulated, non-invasive, never metastasizes .

Malignant : Poorly differentiated to anaplastic, rapid growth, infiltrative border, locally invasive, capable of metastasis .

Dysplasia & Carcinoma In Situ (CIS)

Dysplasia : Disordered epithelial growth and maturation without breaching the basement membrane. Characterized by cellular atypia: hyperchromasia, pleomorphism, increased N/C ratio, loss of polarity, and abnormal mitoses.

Carcinoma In Situ (CIS) : Severe full-thickness dysplasia encompassing the entire thickness of the epithelium without invasion through the basement membrane . Normal Epithelium → Mild/Moderate Dysplasia → Carcinoma In Situ (Full-thickness, Intact Basement Membrane) → Invasive Carcinoma (Breaches Basement Membrane)

TNM Staging System

T (Tumor) : Size and local extent of primary tumor (T1 to T4).

N (Node) : Presence and extent of regional lymph node metastasis (N0 to N3).

M (Metastasis) : Presence of distant metastasis (M0 or M1).

Clinical Significance : Stage (extent of spread) is a far more reliable indicator of prognosis and survival in oral squamous cell carcinoma than Grade (degree of histologic differentiation).

  • Atherosclerosis, Hypertension & Diabetes Mellitus
  • Atherosclerosis Pathogenesis

Initiated by chronic endothelial injury (from smoking, hypertension, hyperlipidemia) → endothelial dysfunction → monocyte adhesion and LDL entrapment in intima → oxidation of LDL → macrophages engulf ox-LDL, becoming Foam Cells → smooth muscle proliferation and collagen deposition forming a fibrous plaque . Rupture of unstable plaque induces acute arterial thrombosis.

Hypertension Guidelines & Dental Safety Protocols

Classification : Normal (<120/<80 mmHg), Elevated (120-129/<80), Stage 1 (130-139/80-89), Stage 2 (>=140 or >=90).

Hypertensive Crisis : BP >180 and/or >120 mmHg. Elective dental care MUST be deferred .

Vasoconstrictor Limit : For patients with Stage 2 hypertension or ischemic heart disease, limit epinephrine to 0.04 mg (maximum 2 cartridges of 1:100,000 epinephrine).

Diabetes Mellitus Complications & Oral Pathology

Type 1 DM : Autoimmune destruction of pancreatic beta cells → absolute insulin deficiency; prone to Diabetic Ketoacidosis (DKA) .

Type 2 DM : Peripheral insulin resistance and relative insulin deficiency; prone to Hyperosmolar Hyperglycemic State (HHS) .

Diagnostic Threshold : HbA1c >= 6.5% or fasting blood glucose >= 126 mg/dL. Target HbA1c for controlled diabetics is < 7.0%.

Complications : Microvascular (Retinopathy, Nephropathy [Kimmelstiel-Wilson nodular glomerulosclerosis], Neuropathy) and Macrovascular (CAD, Stroke, Peripheral Artery Disease).

Oral Manifestations : Periodontal disease is considered the 6th classic complication of diabetes . Diabetic patients present with impaired PMN chemotaxis, delayed wound healing, severe accelerated periodontitis, xerostomia, burning mouth syndrome, and oral candidiasis.